Factors Associated with Hepatitis B Vaccine Response Among Dentists
- 1 May 1994
- journal article
- research article
- Published by SAGE Publications in Journal of Dental Research
- Vol. 73 (5) , 1029-1035
- https://doi.org/10.1177/00220345940730050301
Abstract
The objective of this study was to evaluate personal and immunization factors associated with serologic evidence of hepatitis B virus (HBV) vaccine response. A study was conducted using data from United States dentists participating from 1987 to 1991 in the Health Screening Program of the American Dental Association's annual session. This study included dentists (n = 507) who (1) received their most recent dose of HBV vaccine within the previous 10 months, (2) completed a core questionnaire, and (3) were tested for HBV markers (HBsAg, anti-HBs, and anti-HBc) and were found not to have evidence of past or present infection. Non-responders were defined as dentists testing negative for all three markers (n = 100). Responders were defined as dentists having serological evidence of anti-HBs alone (n = 407). Logistic regression models were used to assess the relationship of vaccine response to the variables sex, age, number of vaccine doses, site of vaccination, type of vaccine, and history of hepatitis. Vaccine response was most strongly associated with sex, age, and number of doses. Factors unrelated to vaccine response included type of vaccine and history of hepatitis. Adherence to the recommended number of doses and early vaccination are critical to adequate protection against hepatitis B infection of dentists, who are often exposed to blood and other body fluids.Keywords
This publication has 12 references indexed in Scilit:
- Development and persistence of antibody in a high risk institutionalized population given plasma-derived hepatitis B vaccineVaccine, 1990
- The Changing Epidemiology of Hepatitis B in the United StatesJAMA, 1990
- Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccinationVaccine, 1989
- Summary of safety and efficacy data on a yeast-derived hepatitis B vaccineThe American Journal of Medicine, 1989
- Persistence of specific antibodies after hepatitis B vaccinationJournal of Hepatology, 1988
- Overview of clinical studies with hepatitis B vaccine made by recombinant DNAJournal of Infection, 1986
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- Hepatitis B Vaccine in Health Care Personnel: Safety, lmmunogenicity, and Indicators of EfficacyAnnals of Internal Medicine, 1984
- Hepatitis B Vaccine in Medical Staff of Hemodialysis UnitsNew England Journal of Medicine, 1982
- Hepatitis B VaccineNew England Journal of Medicine, 1980